|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-8-18
|
|
pubmed:abstractText |
: Weight loss products are frequently used by reproductive-aged women and these products may be taken (inadvertently or intentionally) during pregnancy. This study assessed the association between periconceptional use of weight loss products and major structural birth defects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1542-0760
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
553-62
|
|
pubmed:meshHeading |
pubmed-meshheading:18553492-Abnormalities, Drug-Induced,
pubmed-meshheading:18553492-Adolescent,
pubmed-meshheading:18553492-Adult,
pubmed-meshheading:18553492-Anti-Obesity Agents,
pubmed-meshheading:18553492-Case-Control Studies,
pubmed-meshheading:18553492-Congenital Abnormalities,
pubmed-meshheading:18553492-Ephedra,
pubmed-meshheading:18553492-Female,
pubmed-meshheading:18553492-Humans,
pubmed-meshheading:18553492-Mothers,
pubmed-meshheading:18553492-Phytotherapy,
pubmed-meshheading:18553492-Preconception Care,
pubmed-meshheading:18553492-Pregnancy,
pubmed-meshheading:18553492-Risk Factors,
pubmed-meshheading:18553492-Social Class
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Periconceptional use of weight loss products including ephedra and the association with birth defects.
|
|
pubmed:affiliation |
Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia 30333, USA. dvk2@cdc.gov
|
|
pubmed:publicationType |
Journal Article
|
